ABEO

Abeona Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website abeonatherapeutics.com
Employees(FY) 57
ISIN US00289Y2063

Performance

-5.81%

-13.79%

+9.94%

+30.68%

+14.77%

YTD

+36.26%

Profile

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.

Advanced Technical Analysis

Technical Analysis of ABEO 2024-11-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 23 and the Technical Score at 31, both indicating weakness, while the Oscillators Score at 40 suggests a neutral stance. This combination implies a lack of strong bullish momentum, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ABEO

Stock Rank

Recent News & Updates

2024-11-14 13:06
Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...(Yahoo Finance)
2024-11-13 18:42
Abeona Therapeutics: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-13 18:30
Abeona Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates(Globenewswire)
2024-11-11 18:30
Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa(Globenewswire)
2024-11-03 18:30
Abeona Therapeutics Announces Participation in November Investor Conferences(Globenewswire)
2024-10-31 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-10-28 19:30
Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration(Globenewswire)
2024-10-09 06:13
Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...(Yahoo Finance)
2024-09-30 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-09-02 19:30
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences(Globenewswire)
2024-09-01 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-08-13 19:30
Abeona Therapeutics Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors(Globenewswire)
2024-08-12 19:30
Abeona Therapeutics Announces Favorable Medicare Reimbursement Decisions for Pz-cel(Globenewswire)
2024-08-11 19:37
Abeona Therapeutics: Q2 Earnings Snapshot(Yahoo Finance)
2024-08-11 19:30
Abeona Therapeutics Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission(Globenewswire)
2024-07-31 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-07-10 19:30
Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications(Globenewswire)
2024-07-07 19:30
Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum(Globenewswire)
2024-06-20 15:08
Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)(Yahoo Finance)
2024-06-02 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-05-27 19:30
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference(Globenewswire)
2024-05-15 15:01
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...(Yahoo Finance)
2024-05-15 14:17
Q1 2024 Abeona Therapeutics Inc Earnings Call(Yahoo Finance)
2024-05-15 00:53
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024(Investorplace)
2024-05-14 19:43
Abeona Therapeutics: Q1 Earnings Snapshot(Yahoo Finance)
2024-05-14 19:30
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress(Globenewswire)
2024-05-06 19:30
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-05-02 23:19
Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise(Yahoo Finance)
2024-05-02 19:30
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants(Globenewswire)
2024-04-23 02:04
Top Midday Decliners(Yahoo Finance)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.